Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan · Delayed Price · Currency is TWD 32.80
-0.15 (-0.46%)
Nov 6, 2026, 1:02 PM CST
Sofiva Genomics Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 379.21 | 385.71 | 453.31 | 466.8 | 495.78 | 508.42 |
Revenue Growth | -6.67% | -14.91% | -2.89% | -5.85% | -2.49% | 4.00% |
Gross Profit Gross Profit Growth | 100.71 | 99.13 | 135.66 | 129.91 | 148.99 | 176.81 |
Operating Income Operating Income Growth | -18.62 | -33.74 | -3.37 | -15.88 | 3.79 | 35.24 |
Net Income Net Income Growth | 14.23 | -9.36 | 18.43 | 11.53 | 42.78 | 56.98 |
Earnings Per Share EPS Growth | 0.32 | -0.43 | 0.85 | 0.54 | 2.00 | 2.68 |
EPS Growth | - | - | 57.52% | -73.02% | -25.30% | 65.26% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Other Growth | 17.29 | 17.03 | 18.88 | 14.48 | 13.29 | 12.05 |
Taiwan Taiwan Growth | 361.92 | 368.68 | 434.43 | 452.32 | 482.48 | 496.37 |
Total Total Growth | 379.21 | 385.71 | 453.31 | 466.8 | 495.78 | 508.42 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 131.52 | 124.71 | 146.18 | 140.03 | 170.96 | 245.19 |
Total Debt Total Debt Growth | 38.3 | 35.53 | 53.38 | 63.59 | 74.67 | 85.94 |
Net Cash (Debt) Net Cash Growth | 93.22 | 89.18 | 92.8 | 76.45 | 96.29 | 159.26 |
Net Cash Growth | 33.87% | -3.90% | 21.39% | -20.61% | -39.54% | 35.02% |
Net Cash Per Share Net Cash Per Share Growth | 4.32 | 4.13 | 4.29 | 3.58 | 4.50 | 7.48 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 30.38 | 15.36 | 34.69 | 23.7 | 17.14 | 80.07 |
Capital Expenditures CapEx Growth | -2.24 | -1.16 | -16.92 | -21.01 | -33.53 | -8.16 |
Free Cash Flow Free Cash Flow Growth | 28.15 | 14.2 | 17.77 | 2.69 | -16.4 | 71.91 |
Free Cash Flow Growth | 36.66% | -20.11% | 560.18% | - | - | 58.55% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 26.56% | 25.70% | 29.93% | 27.83% | 30.05% | 34.78% |
Operating Margin | -4.91% | -8.75% | -0.74% | -3.40% | 0.76% | 6.93% |
Pretax Margin | 4.87% | -2.15% | 5.21% | 1.91% | 9.55% | 12.53% |
Profit Margin | 3.75% | -2.43% | 4.07% | 2.47% | 8.63% | 11.21% |
FCF Margin | 7.42% | 3.68% | 3.92% | 0.58% | -3.31% | 14.14% |
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.300 | 0.200 | 1.000 | 2.000 |
Dividend Per Share Growth | 50.00% | -80.00% | -50.00% | 42.86% |
Dividend Yield | 0.75% | 0.49% | 2.73% | 4.10% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 102.43 | - | 46.81 | 75.98 | 18.33 | 18.29 |
Forward PE | - | 12.19 | 12.19 | 12.19 | 12.09 | 18.13 |
P/FCF Ratio | 25.16 | 45.85 | 48.54 | 325.36 | - | 14.49 |
PS Ratio | 1.87 | 1.69 | 1.90 | 1.88 | 1.58 | 2.05 |